Cargando…
Toxicological Evaluation of a Potential Immunosensitizer for Use as a Mucosal Adjuvant—Bacillus thuringiensis Cry1Ac Spore-Crystals: A Possible Inverse Agonist that Deserves Further Investigation
In addition to their applicability as biopesticides, Bacillus thuringiensis (Bt) Cry1Ac spore-crystals are being researched in the immunology field for their potential as adjuvants in mucosal and parenteral immunizations. We aimed to investigate the hematotoxicity and genotoxicity of Bt spore-crysta...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690131/ https://www.ncbi.nlm.nih.gov/pubmed/26690217 http://dx.doi.org/10.3390/toxins7124881 |
_version_ | 1782406961411653632 |
---|---|
author | Mezzomo, Bélin Poletto Miranda-Vilela, Ana Luisa Grisolia, Cesar Koppe |
author_facet | Mezzomo, Bélin Poletto Miranda-Vilela, Ana Luisa Grisolia, Cesar Koppe |
author_sort | Mezzomo, Bélin Poletto |
collection | PubMed |
description | In addition to their applicability as biopesticides, Bacillus thuringiensis (Bt) Cry1Ac spore-crystals are being researched in the immunology field for their potential as adjuvants in mucosal and parenteral immunizations. We aimed to investigate the hematotoxicity and genotoxicity of Bt spore-crystals genetically modified to express Cry1Ac individually, administered orally (p.o.) or with a single intraperitoneal (i.p.) injection 24 h before euthanasia, to simulate the routes of mucosal and parenteral immunizations in Swiss mice. Blood samples were used to perform hemogram, and bone marrow was used for the micronucleus test. Cry1Ac presented cytotoxic effects on erythroid lineage in both routes, being more severe in the i.p. route, which also showed genotoxic effects. The greater severity noted in this route, mainly at 6.75 mg/kg, as well as the intermediate effects at 13.5 mg/kg, and the very low hematotoxicity at 27 mg/kg, suggested a possible inverse agonism. The higher immunogenicity for the p.o. route, particularly at 27 mg/kg, suggested that at this dose, Cry 1Ac could potentially be used as a mucosal adjuvant (but not in parenteral immunizations, due to the genotoxic effects observed). This potential should be investigated further, including making an evaluation of the proposed inverse agonism and carrying out cytokine profiling. |
format | Online Article Text |
id | pubmed-4690131 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-46901312015-12-30 Toxicological Evaluation of a Potential Immunosensitizer for Use as a Mucosal Adjuvant—Bacillus thuringiensis Cry1Ac Spore-Crystals: A Possible Inverse Agonist that Deserves Further Investigation Mezzomo, Bélin Poletto Miranda-Vilela, Ana Luisa Grisolia, Cesar Koppe Toxins (Basel) Article In addition to their applicability as biopesticides, Bacillus thuringiensis (Bt) Cry1Ac spore-crystals are being researched in the immunology field for their potential as adjuvants in mucosal and parenteral immunizations. We aimed to investigate the hematotoxicity and genotoxicity of Bt spore-crystals genetically modified to express Cry1Ac individually, administered orally (p.o.) or with a single intraperitoneal (i.p.) injection 24 h before euthanasia, to simulate the routes of mucosal and parenteral immunizations in Swiss mice. Blood samples were used to perform hemogram, and bone marrow was used for the micronucleus test. Cry1Ac presented cytotoxic effects on erythroid lineage in both routes, being more severe in the i.p. route, which also showed genotoxic effects. The greater severity noted in this route, mainly at 6.75 mg/kg, as well as the intermediate effects at 13.5 mg/kg, and the very low hematotoxicity at 27 mg/kg, suggested a possible inverse agonism. The higher immunogenicity for the p.o. route, particularly at 27 mg/kg, suggested that at this dose, Cry 1Ac could potentially be used as a mucosal adjuvant (but not in parenteral immunizations, due to the genotoxic effects observed). This potential should be investigated further, including making an evaluation of the proposed inverse agonism and carrying out cytokine profiling. MDPI 2015-12-09 /pmc/articles/PMC4690131/ /pubmed/26690217 http://dx.doi.org/10.3390/toxins7124881 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mezzomo, Bélin Poletto Miranda-Vilela, Ana Luisa Grisolia, Cesar Koppe Toxicological Evaluation of a Potential Immunosensitizer for Use as a Mucosal Adjuvant—Bacillus thuringiensis Cry1Ac Spore-Crystals: A Possible Inverse Agonist that Deserves Further Investigation |
title | Toxicological Evaluation of a Potential Immunosensitizer for Use as a Mucosal Adjuvant—Bacillus thuringiensis Cry1Ac Spore-Crystals: A Possible Inverse Agonist that Deserves Further Investigation |
title_full | Toxicological Evaluation of a Potential Immunosensitizer for Use as a Mucosal Adjuvant—Bacillus thuringiensis Cry1Ac Spore-Crystals: A Possible Inverse Agonist that Deserves Further Investigation |
title_fullStr | Toxicological Evaluation of a Potential Immunosensitizer for Use as a Mucosal Adjuvant—Bacillus thuringiensis Cry1Ac Spore-Crystals: A Possible Inverse Agonist that Deserves Further Investigation |
title_full_unstemmed | Toxicological Evaluation of a Potential Immunosensitizer for Use as a Mucosal Adjuvant—Bacillus thuringiensis Cry1Ac Spore-Crystals: A Possible Inverse Agonist that Deserves Further Investigation |
title_short | Toxicological Evaluation of a Potential Immunosensitizer for Use as a Mucosal Adjuvant—Bacillus thuringiensis Cry1Ac Spore-Crystals: A Possible Inverse Agonist that Deserves Further Investigation |
title_sort | toxicological evaluation of a potential immunosensitizer for use as a mucosal adjuvant—bacillus thuringiensis cry1ac spore-crystals: a possible inverse agonist that deserves further investigation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690131/ https://www.ncbi.nlm.nih.gov/pubmed/26690217 http://dx.doi.org/10.3390/toxins7124881 |
work_keys_str_mv | AT mezzomobelinpoletto toxicologicalevaluationofapotentialimmunosensitizerforuseasamucosaladjuvantbacillusthuringiensiscry1acsporecrystalsapossibleinverseagonistthatdeservesfurtherinvestigation AT mirandavilelaanaluisa toxicologicalevaluationofapotentialimmunosensitizerforuseasamucosaladjuvantbacillusthuringiensiscry1acsporecrystalsapossibleinverseagonistthatdeservesfurtherinvestigation AT grisoliacesarkoppe toxicologicalevaluationofapotentialimmunosensitizerforuseasamucosaladjuvantbacillusthuringiensiscry1acsporecrystalsapossibleinverseagonistthatdeservesfurtherinvestigation |